ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,067, issued on March 11, was assigned to BioNTech US Inc. (Cambridge, Mass.).
"Neoantigens and uses thereof" was invented by Vikram Juneja (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein relates to immunotherapeutic compositions comprising immunotherapeutic peptides comprising neoepitopes, polynucleotides encoding the immunotherapeutic peptides, antigen presenting cells comprising the immunotherapeutic peptides or polynucleotides, or T cell receptors specific for the neoepitopes. Also disclosed herein is use of the immunotherapeutic compositions."
The patent was filed on June 19, 2019, under Application No. 17/254,1...